The Intermedics Intertach 262–12 tachycardia reversion pulse generator was implanted in
14 patients (six male, eight female, mean age at implantation 45±16 years) with recurrent …

The purpose of this study was to investigate the efficacy and safety of antitachycardia pacing
(ATP) in third‐generation implantable Cardioverter defibrillators (ICDs) for terminating …

Several studies have analyzed the efficacy of a variety of antitachycardia pacing (ATP)
modalities in induced and spontaneous monomorphic ventricular tachycardia (MVT). 1–18 …

We evaluated to what extent multiple attempts of antitachycardia pacing (ATP) are useful in
patients with implantable cardioverter-defibrillators (ICD). Devices of 38 patients with …

The efficacy of antitachycardia pacing (ATP) incorporated into implantable cardioverter
defibrillators (ICDs) was assessed in 29 consecutive survivors of cardiac arrest, not …

Aims Little is known about the optimal number of antitachycardia pacing (ATP) attempts to
programme in the fast ventricular tachycardia (FVT) zone. We sought to analyse the long …

Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD)
decreases patient shock burden but has recognized limitations. A new automated ATP …

Intrinsic anti-tachycardia pacing (iATP) is a novel automated ATP algorithm that employs
post-pacing interval (PPI) to design the next ATP sequence based on an analysis of the prior …

A pacemaker was used to control drug‐resistant reentrant Supraventricular tachycardia
(SVT) in 40 patients. An antitachycardia pacemaker was impJanted in 37 for SVT; in one for …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful
tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for those patients …